Usana Health Sciences (USNA) Revenue (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Revenue data on file, last reported at $250.2 million in Q2 2026.

• Revenue for Q2 2026 came in at $250.2 million, changed 0.27% year-over-year; the trailing twelve-month figure through Apr 2026 was $925.9 million (up 5.67% YoY), and the FY2026 annual result was $925.3 million, up 8.28% from the prior year.
• Revenue rose to $250.2 million in Q2 2026 per USNA's latest filing, from $226.2 million in the prior quarter.
• Over five years, Revenue peaked at $362.3 million in Q1 2022 and troughed at $200.2 million in Q3 2024.
• A 5-year average of $239.6 million and a median of $230.6 million in 2022 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue tumbled 37.09% in 2022, then climbed 10.79% in 2025.
• A 5-year view of Revenue shows it stood at $228.0 million in 2022, then retreated by 3.02% to $221.1 million in 2023, then decreased by 3.38% to $213.6 million in 2024, then gained by 0.03% to $213.7 million in 2025, then advanced by 17.1% to $250.2 million in 2026.
• Business Quant data shows USNA's Revenue at $250.2 million in Q2 2026, $226.2 million in Q1 2026, and $213.7 million in Q3 2025.